Argonaut Awarded SBIR Grant for Manufacturing of Fine Chemicals.Business Editors/Health & Medical Writers FOSTER CITY, Calif.--(BW HealthWire)--Dec. 18, 2001 Argonaut Technologies, Inc. (Nasdaq:AGNT AGNT Association for Global New Thought AGNT Agent Table ) today announced the receipt of a Small Business Innovation Research (SBIR SBIR Small Business Innovation Research (program/grant) SBIR Space Based Infra-Red SBIR Speaker-Boundary Interference SBIR Site Backsurface-referenced Ideal Plane/Range (silicon wafers) ) grant awarded by the office of the National Science Foundation (NSF NSF - National Science Foundation ). The grant will be used to fund research focused on the technical and commercial feasibility of a new class of polymer-supported palladium catalysts. Several widely used chemical methodologies, Suzuki and Heck reactions The Heck reaction (also called the Mizoroki-Heck reaction) is the chemical reaction of an unsaturated halide (or triflate) with an alkene and a strong base and palladium catalyst to form a substituted alkene. , require homogeneous palladium catalysts and are generally restricted to smaller scale reactions in R&D efforts. The use of homogeneous palladium-catalyzed reactions is of great interest for fine chemical manufacturing for reasons of synthetic efficiency and reduced environmental waste. However, scientists are reluctant to adopt these methodologies for commercial fine chemical manufacturing, because of difficulties associated with the use of homogeneous catalysts. The potential development of polymer supported catalysts could significantly aid the adoption of these reactions in commercial settings. "The SBIR grant award for the development of this new class of polymers further validates Argonaut's chemistry expertise," stated Jeff Labadie, Ph.D., Argonaut's Vice President, Chemistry. "We are finding that our ability to creatively address chemistry bottlenecks, not only with instrumentation, but also with the development of novel reagents and polymers is critical to our success with pharmaceutical and chemical companies." Argonaut Technologies Argonaut Technologies, Inc. is a pioneer in the development of innovative products that speed and simplify how chemists discover and test new chemical entities. Our products enable chemists to increase their productivity, reduce their operating costs operating costs npl → gastos mpl operacionales through automation and process simplification, achieve faster time-to-market for new products, and cost-effectively explore the increasing number of drug targets available for drug development. We provide solutions that are used in over 825 pharmaceutical, chemical and academic laboratories worldwide. Our instruments, software and consumables for parallel synthesis enable chemists to perform multiple experiments under a variety of conditions in a fraction of the time and cost of traditional methods. Forward Looking Statements Statements included in this press release that are not historical in nature may be "forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. " within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Examples of such forward-looking statements include, without limitation, statements regarding anticipated results of our research and statements about the ability of our products to enhance chemical development. Any such forward-looking statements involve risks and uncertainties and reflect Argonaut's judgment as of the date of this release. These and other risk factors are discussed in Argonaut's Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended December 31, 2000 filed on April 2, 2001, as amended, in its most recent quarterly report on Form 10-Q Form 10-Q See 10-Q. for the quarter ended September 30, 2001 filed on November 13, 2001, and its other filings with the Securities and Exchange Commission. Argonaut disclaims any intent or obligation to update these forward-looking statements. The Company claims the protection of the Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion